{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T18:18:19Z","timestamp":1787941099523,"version":"build-2784847793"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002562","name":"Sunchon National University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002562","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Prolactin, a hormone with emerging neuroprotective roles, has demonstrated potential in mitigating cognitive impairment under specific neurotoxic conditions, including environmental toxicity and excitotoxicity. While dopamine D2 receptor (D2R) antagonists, such as risperidone, can elevate systemic prolactin levels to exert beneficial effects in the central nervous system (CNS), their clinical repurposing is constrained by CNS-mediated side effects associated with blood\u2013brain barrier (BBB) penetration. In this study, we aimed to identify novel D2R antagonist candidates predicted to have restricted BBB penetration and the potential to stimulate prolactin secretion without substantial CNS exposure, thereby reducing central side effects including extrapyramidal symptoms and sedation. A systematic multi-stage in silico screening workflow was implemented. Ligand-based virtual screening using SwissSimilarity against the ZINC-20 database identified 400 structural analogs of risperidone. SwissADME-based ADMET filtering selected 226 candidates predicted to be BBB-impermeable, from which molecular docking using AutoDock Vina identified eight compounds with docking scores more favorable than that of risperidone. Subsequent interaction analysis identified four candidates that maintained critical contacts with Asp80 (3.32) and Trp373 (6.48), key residues involved in D2R ligand binding. Molecular dynamics simulations over 100 ns were used to assess conformational behavior, with Compound #128 exhibiting the most favorable ligand stability profile among the tested candidates and showing behavior broadly comparable to that of risperidone. These findings suggest that the identified compounds may serve as computationally prioritized candidates for the development of peripherally restricted D2R antagonists. However, their functional D2R antagonism, actual BBB exclusion, prolactin-elevating activity, and ability to reproduce CNS neuroprotection without direct central D2R modulation remain to be experimentally validated.<\/jats:p>","DOI":"10.1371\/journal.pone.0355997","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T17:31:23Z","timestamp":1787938283000},"page":"e0355997","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of novel peripherally restricted risperidone-like dopamine D2 receptor antagonists for prolactin-mediated neuroprotection through a multi-stage in silico screening"],"prefix":"10.1371","volume":"21","author":[{"given":"Shinhyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Hee","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Ok","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9952-0038","authenticated-orcid":true,"given":"Min-Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"pone.0355997.ref001","doi-asserted-by":"crossref","first-page":"1002320","DOI":"10.3389\/fendo.2022.1002320","article-title":"Metabolic effects of prolactin and the role of dopamine agonists: A review","volume":"13","author":"P Kirsch","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"pone.0355997.ref002","unstructured":"Al-Chalabi M, Bass AN, Alsalman I. Physiology, prolactin. 2018."},{"issue":"4","key":"pone.0355997.ref003","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","article-title":"Prolactin: structure, function, and regulation of secretion","volume":"80","author":"ME Freeman","year":"2000","journal-title":"Physiol Rev"},{"issue":"5603","key":"pone.0355997.ref004","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1076647","article-title":"Pregnancy-stimulated neurogenesis in the adult female forebrain mediated by prolactin","volume":"299","author":"T Shingo","year":"2003","journal-title":"Science"},{"issue":"8","key":"pone.0355997.ref005","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nn1928","article-title":"Male pheromone-stimulated neurogenesis in the adult female brain: possible role in mating behavior","volume":"10","author":"GK Mak","year":"2007","journal-title":"Nat Neurosci"},{"issue":"6","key":"pone.0355997.ref006","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1523\/JNEUROSCI.3178-08.2009","article-title":"Prolactin prevents chronic stress-induced decrease of adult hippocampal neurogenesis and promotes neuronal fate","volume":"29","author":"L Torner","year":"2009","journal-title":"J Neurosci"},{"issue":"2","key":"pone.0355997.ref007","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1677\/joe.0.1730219","article-title":"Roles of prolactin and related members of the prolactin\/growth hormone\/placental lactogen family in angiogenesis","volume":"173","author":"AM Corbacho","year":"2002","journal-title":"J Endocrinol"},{"key":"pone.0355997.ref008","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neulet.2019.02.027","article-title":"Prolactin prevents mitochondrial dysfunction induced by glutamate excitotoxicity in hippocampal neurons","volume":"701","author":"NA Rivero-Segura","year":"2019","journal-title":"Neurosci Lett"},{"issue":"5","key":"pone.0355997.ref009","article-title":"Prolactin-induced neuroprotection against glutamate excitotoxicity is mediated by the reduction of [Ca2+]i overload and NF-\u03baB activation","volume":"12","author":"NA Rivero-Segura","year":"2017","journal-title":"PLoS One"},{"key":"pone.0355997.ref010","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.brainres.2016.02.011","article-title":"Prolactin mediates neuroprotection against excitotoxicity in primary cell cultures of hippocampal neurons via its receptor","volume":"1636","author":"E Vergara-Casta\u00f1eda","year":"2016","journal-title":"Brain Res"},{"issue":"1","key":"pone.0355997.ref011","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.yhbeh.2007.09.004","article-title":"Neuroprotective effects of lactation against kainic acid treatment in the dorsal hippocampus of the rat","volume":"53","author":"A Vanoye-Carlo","year":"2008","journal-title":"Horm Behav"},{"issue":"3","key":"pone.0355997.ref012","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.neuroscience.2010.05.074","article-title":"Prolactin reduces the damaging effects of excitotoxicity in the dorsal hippocampus of the female rat independently of ovarian hormones","volume":"169","author":"D Tejadilla","year":"2010","journal-title":"Neuroscience"},{"key":"pone.0355997.ref013","unstructured":"Kokoeva MV. Prolactin-induced neurogenesis and gene expression networks in the adult hippocampus. 2007."},{"key":"pone.0355997.ref014","doi-asserted-by":"crossref","first-page":"109726","DOI":"10.1016\/j.intimp.2023.109726","article-title":"Risperidone ameliorated 1,2-Diacetylbenzene-induced cognitive impairments in mice via activating prolactin signaling pathways","volume":"115","author":"HD Nguyen","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"pone.0355997.ref015","doi-asserted-by":"crossref","first-page":"104418","DOI":"10.1016\/j.etap.2024.104418","article-title":"Role of prolactin in the protective effect of amisulpride against 1,2-Diacetylbenzene\u2019s neurotoxicity","volume":"107","author":"NM-H Hoang","year":"2024","journal-title":"Environ Toxicol Pharmacol"},{"key":"pone.0355997.ref016","doi-asserted-by":"crossref","first-page":"656370","DOI":"10.1155\/2014\/656370","article-title":"Second-generation antipsychotics and extrapyramidal adverse effects","volume":"2014","author":"N Divac","year":"2014","journal-title":"Biomed Res Int"},{"issue":"3","key":"pone.0355997.ref017","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00004714-199706000-00010","article-title":"Extrapyramidal symptoms in patients treated with risperidone","volume":"17","author":"GM Simpson","year":"1997","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"pone.0355997.ref018","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1600-0447.2009.01429.x","article-title":"Amisulpride - dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring","volume":"120","author":"A Sparshatt","year":"2009","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"pone.0355997.ref019","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/0019-5545.130510","article-title":"Extrapyramidal side effects with low doses of amisulpride","volume":"56","author":"N Mandal","year":"2014","journal-title":"Indian J Psychiatry"},{"issue":"4","key":"pone.0355997.ref020","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1192\/apt.bp.115.014928","article-title":"Management of antipsychotic-induced hyperprolactinaemia","volume":"23","author":"S Gupta","year":"2017","journal-title":"BJPsych advances"},{"issue":"1","key":"pone.0355997.ref021","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1192\/bja.2019.49","article-title":"Understanding and managing cardiac side-effects of second-generation antipsychotics in the treatment of schizophrenia","volume":"26","author":"M Sweeney","year":"2019","journal-title":"BJPsych advances"},{"issue":"7695","key":"pone.0355997.ref022","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nature25758","article-title":"Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone","volume":"555","author":"S Wang","year":"2018","journal-title":"Nature"},{"issue":"23","key":"pone.0355997.ref023","doi-asserted-by":"crossref","first-page":"14748","DOI":"10.1021\/acsomega.0c05984","article-title":"In Silico Repositioning of Dopamine Modulators with Possible Application to Schizophrenia: Pharmacophore Mapping, Molecular Docking and Molecular Dynamics Analysis","volume":"6","author":"M Mejia-Gutierrez","year":"2021","journal-title":"ACS Omega"},{"issue":"10","key":"pone.0355997.ref024","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1021\/acs.jcim.4c02101","article-title":"Insights into Ligand-Specific Activation Dynamics of Dopamine D2 Receptor Explored by MD Simulations","volume":"65","author":"S Mansoor","year":"2025","journal-title":"J Chem Inf Model"},{"key":"pone.0355997.ref025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding","volume":"124","author":"A Schotte","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"pone.0355997.ref026","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2147\/NDT.S14385","article-title":"Clinical utility of the risperidone formulations in the management of schizophrenia","volume":"7","author":"V Madaan","year":"2011","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"2","key":"pone.0355997.ref027","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41594-018-0180-z","article-title":"Structures of the 5-HT2A receptor in complex with the antipsychotics risperidone and zotepine","volume":"26","author":"KT Kimura","year":"2019","journal-title":"Nat Struct Mol Biol"},{"issue":"7354","key":"pone.0355997.ref028","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature10236","article-title":"Structure of the human histamine H1 receptor complex with doxepin","volume":"475","author":"T Shimamura","year":"2011","journal-title":"Nature"},{"issue":"1","key":"pone.0355997.ref029","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41467-021-27911-3","article-title":"Crystal structure of the \u03b11B-adrenergic receptor reveals molecular determinants of selective ligand recognition","volume":"13","author":"M Deluigi","year":"2022","journal-title":"Nat Commun"},{"issue":"8","key":"pone.0355997.ref030","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1021\/acs.jcim.6b00174","article-title":"SwissSimilarity: A Web Tool for Low to Ultra High Throughput Ligand-Based Virtual Screening","volume":"56","author":"V Zoete","year":"2016","journal-title":"J Chem Inf Model"},{"issue":"12","key":"pone.0355997.ref031","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1021\/acs.jcim.0c00675","article-title":"ZINC20-A Free Ultralarge-Scale Chemical Database for Ligand Discovery","volume":"60","author":"JJ Irwin","year":"2020","journal-title":"J Chem Inf Model"},{"key":"pone.0355997.ref032","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"A Daina","year":"2017","journal-title":"Sci Rep"},{"key":"pone.0355997.ref033","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"CA Lipinski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"pone.0355997.ref034","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A BOILED-Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules","volume":"11","author":"A Daina","year":"2016","journal-title":"ChemMedChem"},{"issue":"9","key":"pone.0355997.ref035","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures","volume":"58","author":"DEV Pires","year":"2015","journal-title":"J Med Chem"},{"key":"pone.0355997.ref036","article-title":"ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support","volume":"52","author":"L Fu","year":"2024","journal-title":"Nucleic acids research"},{"key":"pone.0355997.ref037","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"A Waterhouse","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"pone.0355997.ref038","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings","volume":"61","author":"J Eberhardt","year":"2021","journal-title":"J Chem Inf Model"},{"issue":"2","key":"pone.0355997.ref039","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1021\/acschemneuro.5b00271","article-title":"Binding Interactions of Dopamine and Apomorphine in D2High and D2Low States of Human Dopamine D2 Receptor Using Computational and Experimental Techniques","volume":"7","author":"S Durdagi","year":"2016","journal-title":"ACS Chem Neurosci"},{"issue":"11","key":"pone.0355997.ref040","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: a web-based graphical user interface for CHARMM","volume":"29","author":"S Jo","year":"2008","journal-title":"J Comput Chem"},{"issue":"4","key":"pone.0355997.ref041","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10822-019-00194-z","article-title":"Significantly different effects of tetrahydroberberrubine enantiomers on dopamine D1\/D2 receptors revealed by experimental study and integrated in silico simulation","volume":"33","author":"H Ge","year":"2019","journal-title":"J Comput Aided Mol Des"},{"issue":"4","key":"pone.0355997.ref042","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"31","author":"K Vanommeslaeghe","year":"2010","journal-title":"J Comput Chem"},{"key":"pone.0355997.ref043","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: A linear constraint solver for molecular simulations","volume":"18","author":"B Hess","year":"1997","journal-title":"J Comput Chem"},{"issue":"4","key":"pone.0355997.ref044","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1345\/aph.18003","article-title":"Domperidone: a peripherally acting dopamine2-receptor antagonist","volume":"33","author":"JA Barone","year":"1999","journal-title":"Ann Pharmacother"},{"issue":"1416","key":"pone.0355997.ref045","first-page":"66","article-title":"Domperidone safety: a mini-review of the science of QT prolongation and clinical implications of recent global regulatory recommendations","volume":"128","author":"PJ Buffery","year":"2015","journal-title":"N Z Med J"},{"issue":"3","key":"pone.0355997.ref046","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/157488610791698334","article-title":"Domperidone and long QT syndrome","volume":"5","author":"M Rossi","year":"2010","journal-title":"Curr Drug Saf"},{"key":"pone.0355997.ref047","volume-title":"FDA warns against women using unapproved drug, domperidone, to increase milk production","year":"2004"},{"issue":"4","key":"pone.0355997.ref048","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4212\/cjhp.v67i4.1378","article-title":"Sudden Cardiac Death and Ventricular Arrhythmias Associated with Domperidone: Evidence Supporting Health Canada\u2019s Warning","volume":"67","author":"S Kanji","year":"2014","journal-title":"Can J Hosp Pharm"},{"issue":"1","key":"pone.0355997.ref049","doi-asserted-by":"crossref","DOI":"10.1136\/bmjquality.u209711.w4039","article-title":"Improving the safety of prescriptions of domperidone in primary care: implementing MHRA advice","volume":"5","author":"W Hall","year":"2016","journal-title":"BMJ Qual Improv Rep"},{"issue":"2","key":"pone.0355997.ref050","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11096-019-00803-9","article-title":"Critical review of European Medicines Agency (EMA) assessment report and related literature on domperidone","volume":"41","author":"K Y\u00fcksel","year":"2019","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"pone.0355997.ref051","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1038\/s41598-018-25036-0","article-title":"In Vitro and In Vivo Characterization of PCC0104005, a Novel Modulator of Serotonin-Dopamine Activity, as an Atypical Antipsychotic Drug","volume":"8","author":"Y Xu","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"pone.0355997.ref052","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00210-017-1364-5","article-title":"Inhibition of cloned hERG potassium channels by risperidone and paliperidone","volume":"390","author":"HJ Lee","year":"2017","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"pone.0355997.ref053","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000519552","article-title":"Association between Serum Prolactin Levels and Neurodegenerative Diseases: Systematic Review and Meta-Analysis","volume":"29","author":"H Duc Nguyen","year":"2022","journal-title":"Neuroimmunomodulation"},{"key":"pone.0355997.ref054","author":"J Kaur","year":"2025"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0355997","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T17:31:33Z","timestamp":1787938293000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0355997"}},"subtitle":[],"editor":[{"given":"Lalit","family":"Samant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":54,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0355997","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]}}}